(Q46155234)

English

The effect of rosiglitazone on integrated cardiovascular performance, cardiac structure, function and myocardial triglyceride: trial design and rationale

scientific article published in January 2009

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19156629

The effect of rosiglitazone on integrated cardiovascular performance, cardiac structure, function and myocardial triglyceride: trial design and rationale (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19156629

1 reference

based on heuristic

inferred from title

(RS)-rosiglitazone

1 reference

based on heuristic

inferred from title

Darren K McGuire

1

object named as

Darren K McGuire

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19156629

6

object named as

Colby R Ayers

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19156629

author name string

Raphael See

2

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19156629

Shuaib M Abdullah

3

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19156629

Peter G Snell

4

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19156629

Jonathan M McGavock

5

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19156629

Lidia S Szczepaniak

7

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19156629

language of work or name

0 references

publication date

1 January 2009

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19156629

Diabetes and Vascular Disease Research

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19156629

6

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19156629

1

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19156629

43-50

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19156629

Thiazolidinediones

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.009

21 January 2018

Thiazolidinediones, peripheral oedema and congestive heart failure: what is the evidence?

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.009

21 January 2018

The PROactive study: some answers, many questions

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.009

21 January 2018

Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.009

21 January 2018

New drugs for the treatment of diabetes mellitus: part I: Thiazolidinediones and their evolving cardiovascular implications

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.009

21 January 2018

Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.009

21 January 2018

Cardiac and glycemic benefits of troglitazone treatment in NIDDM. The Troglitazone Study Group.

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.009

21 January 2018

A comparison of the effects of rosiglitazone and glyburide on cardiovascular function and glycemic control in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.009

21 January 2018

A randomized, placebo-controlled trial assessing the effects of rosiglitazone on echocardiographic function and cardiac status in type 2 diabetic patients with New York Heart Association Functional Class I or II Heart Failure.

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.009

21 January 2018

Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retention

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.009

21 January 2018

Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.009

21 January 2018

Fluid retention after initiation of thiazolidinedione therapy in diabetic patients with established chronic heart failure

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.009

21 January 2018

The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health.

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.009

21 January 2018

Standards of medical care in diabetes--2008.

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.009

21 January 2018

Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 Years

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.009

21 January 2018

Assessment of habitual physical activity by a seven-day recall in a community survey and controlled experiments

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.009

21 January 2018

Cardiac output by rebreathing in patients with cardiopulmonary diseases

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.009

21 January 2018

Cerebral versus systemic hemodynamics during graded orthostatic stress in humans

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.009

21 January 2018

Methods and reproducibility of cardiac/respiratory double-triggered (1)H-MR spectroscopy of the human heart

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.009

21 January 2018

Once- and twice-daily dosing with rosiglitazone improves glycemic control in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.009

21 January 2018

Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group.

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.009

21 January 2018

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.009

21 January 2018

Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.009

21 January 2018

Effect of various diuretic treatments on rosiglitazone-induced fluid retention.

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.009

21 January 2018

Effects of pioglitazone on calcium channels in vascular smooth muscle.

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.009

21 January 2018

Troglitazone treatment increases plasma vascular endothelial growth factor in diabetic patients and its mRNA in 3T3-L1 adipocytes

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.009

21 January 2018

The oral insulin sensitizer, thiazolidinedione, increases plasma vascular endothelial growth factor in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.009

21 January 2018

The physiological meaning of the maximal oxygen intake test

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.009

21 January 2018

Rosiglitazone improves exercise capacity in individuals with type 2 diabetes

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.009

21 January 2018

Assessment of systolic left ventricular function: a multi-centre comparison of cineventriculography, cardiac magnetic resonance imaging, unenhanced and contrast-enhanced echocardiography.

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.009

21 January 2018

Magnetic resonance imaging compared to echocardiography to assess left ventricular mass in the hypertensive patient.

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.009

21 January 2018

Role of nitric oxide in obesity-induced beta cell disease

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.009

21 January 2018

Lipotoxic heart disease in obese rats: implications for human obesity

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.009

21 January 2018

Proton NMR spectroscopy in canine myocardial infarction

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.009

21 January 2018

Water-suppressed one-dimensional 1H NMR chemical shift imaging of the heart before and after regional ischemia

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.009

21 January 2018

Determination of triglyceride in the human myocardium by magnetic resonance spectroscopy: reproducibility and sensitivity of the method

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.009

21 January 2018

Identifiers

10.3132/DVDR.2009.009

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19156629

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19156629

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46155234&oldid=2095239332"